GSE132374
ATAC-seq analysis of human breast cancer cell lines treated with abemaciclib
We measured changes in chromatin accessibility after treatment of human breast cancer cell lines with abemaciclib Overall design: Examination of changes in ATAC-seq signal in duplicate